news ‘Chemical cube’ tools for building new drugs 29 March 2023 | By Ria Kakkad (Drug Target Review) In an ongoing discovery programme, a chemical-creation platform is being revealed – based on cubic molecules – that could help breathe new life into tired drugs.
news Exosome formulation developed for choroidal neovascularisation therapy 27 July 2021 | By Anna Begley (Drug Target Review) An exosome formulation has been created to deliver vascular endothelial-growth factor (VEGF) antibodies for choroidal neovascularisation therapy in models.
news Screening 10,000 compounds identifies six potential COVID-19 therapeutics 17 April 2020 | By Hannah Balfour (Drug Target Review) High-throughput screening of thousands of compounds has revealed several candidates, including lead compound ebselen, with the potential for treating COVID-19.
news Metal-containing compounds could lead to new antibacterials 2 March 2020 | By Hannah Balfour (Drug Target Review) International collaboration has shown that compounds with metals in them show antibacterial activity against MRSA, E. coli and A. baumannii.